Related Experiment Video
Updated: May 3, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
Upper airway cough syndrome in children and two inflammatory factors: TRPV1 and TGF-β2
Ying-Xia Lu1, Qing-Long Gu1, Jun Du1
1Department of Otolaryngology-Head and Neck Surgery, Capital Institute of Pediatrics affiliated children's hospital, Beijing, China.
Insights
Elevated TRPV1 and TGF-β2 levels in children indicate upper airway cough syndrome (UACS). This study explored these inflammatory factors and identified tonsil hypertrophy as a risk factor for UACS.
Area of Science:
- Pediatric Otolaryngology
- Immunology
- Respiratory Medicine
Background:
- Upper airway cough syndrome (UACS) is a common cause of chronic cough in children.
- The role of specific inflammatory markers like TRPV1 and TGF-β2 in UACS pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate upper airway cough syndrome (UACS) in children.
- To explore the relationships among TRPV1, TGF-β2, and UACS.
- To identify potential diagnostic markers and risk factors for UACS in pediatric patients.
Main Methods:
- 104 children (aged 2-13) with adenoid hypertrophy were included.
- Enzyme-linked immunosorbent assay (ELISA) and immunohistochemical (IHC) studies were performed for TRPV1 and TGF-β2.
- Correlations between inflammatory markers, clinical factors, and UACS diagnosis were analyzed across three study stages.
Main Results:
- TRPV1 and TGF-β2 levels were significantly elevated in children with UACS.
- Obstructive sleep apnea-hypopnea syndrome (OSAHS) and thick mucus secretions correlated with UACS diagnosis.
- Asthma history and thick mucus secretions were associated with increased inflammatory factor levels.
Conclusions:
- Serum and adenoid body detection of TRPV1 and TGF-β2 can aid in auxiliary diagnosis of UACS.
- Tonsil hypertrophy and a history of chronic tonsillitis are identified as independent risk factors for UACS in children.
Objectives:
The aim of the study was to investigate upper airway cough syndrome (UACS) in children and to determine alternative methods to explore the relationships among TRPV1, TGF-β2, and UACS.
Methods:
In 2012, 104 children with adenoid hypertrophy aged 2-13 years who were admitted to the otolaryngology department, Capital Institute of Pediatrics-affiliated children's hospital, were included in this study. Enzyme-linked immunosorbent assay (ELISA) and immunohistochemical (IHC) studies for TRPV1 and TGF-β2 were performed to understand the relationship between the two inflammatory factors, and the correlations among the indices and UACS. The research was divided into three stages. In stage 1, 72 children (24 UACS and 48 controls) were enrolled in the study, and ELISAs for TRPV1 and TGF-β2 were performed. In stage 2, 32 children (16 UACS and 16 controls) were enrolled in the study and both ELISA and IHC for TRPV1 and TGF-β2 were performed. In stage 3, 41 children were enrolled in this research who had thick mucus secretions in the posterior nasal apertures in stage 1 and 2 (23 cases with chief complaint (or history) of chronic cough and 18 cases without). The difference between the TRPV1 and TGF-β2 serum values and the clinical factors was determined.
Results:
The levels of TRPV1 and TGF-β2 were significantly increased in the UACS cases. OSAHS and thick mucus secretions correlated with a diagnosis of UACS. A history of asthma and thick mucus secretions correlated with elevation of the two inflammatory factors. There was no statistical correlation between ELISA and IHC testing. Among the children with thick mucus secretions, some had a higher possibility of chronic coughing including those who had higher levels of the two indices, larger tonsils and a history of chronic tonsillitis.
Conclusion:
The detections of TRPV1 and TGF-β2 from serum and adenoid body specimens are valuable for UACS auxiliary diagnosis. Tonsil hypertrophy and chronic tonsillitis history are independent risk factors of UACS.
More Related Videos
Related Concept Videos
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
Asthma-I: Introduction

